UV-A1 phototherapy for sclerotic skin diseases: Implications for optimizing patient selection and management

Archives of Dermatology

Volumn 144, Issue 7, 2008, Pages 912-916

  Kreuter, Alexander ^a   Gambichler, Thilo ^b  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE;

CLINICAL TRIAL; ECHOGRAPHY; EDITORIAL; GRAFT VERSUS HOST REACTION; HEALTH CARE COST; HUMAN; LICHEN SCLEROSUS ET ATROPHICUS; LOCALIZED SCLERODERMA; MORPHEA; PATIENT CARE; PATIENT SELECTION; PHOTOTHERAPY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; SCLERODERMA; SYSTEMIC SCLEROSIS; TREATMENT RESPONSE; ULTRAVIOLET A RADIATION;

DECISION SUPPORT TECHNIQUES; HUMANS; PATIENT SELECTION; SCLERODERMA, LOCALIZED; ULTRAVIOLET THERAPY;

EID: 47849094384     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.144.7.912     Document Type: Editorial

References (33)

1. Mutzhas MF, Hölzle E, Hofmann C, Plewig G. A new apparatus with high radiation energy between 320-460 nm: physical description and dermatological applications. J Invest Dermatol. 1981;76(1):42-47.
2. Krutmann J, Schöpf E. High-dose-UVA1 phototherapy: a novel and highly effective approach for the treatment of acute exacerbation of atopic dermatitis. Acta Derm Venereol Suppl (Stockh). 1992;176:120-122.
3. Kerscher M, Dirschka T, Volkenandt M. Treatment of localised scleroderma by UVA1 phototherapy [letter]. Lancet. 1995;346(8983):1166.
4. Wang F, Garza LA, Cho S, et al. Effect of increased pigmentation on the antifibrotic response of human skin to UV-A1 phototherapy. Arch Dermatol. 2008; 144(7):851-858.
5. Stege H, Berneburg M, Humke S, et al. High-dose UVA1 radiation therapy for localized scleroderma. J Am Acad Dermatol. 1997;36(6, pt 1):938-944.
6. Kerscher M, Volkenendt M, Gruss C, et al. Low-dose UVA1 phototherapy for treatment of localized scleroderma. J Am Acad Dermatol. 1998;38(1):21-26.
7. Camacho NR, Sanchez JE, Martin RF, Gonzalez JR, Sanchez JL. Medium-dose UVA1 phototherapy in localized scleroderma and its effect in CD34-positive dendritic cells. J Am Acad Dermatol. 2001;45(5):697-699.
8. Kreuter A, Gambicher T, Avermaete A, et al. Combined treatment with calcipotriol ointment and low-dose ultraviolet A1 phototherapy in childhood morphea. Pediatr Dermatol. 2001;18(3):241-245.
9. de Rie MA, Enomoto DNH, de Vries HJC, Bos JD. Evaluation of medium-dose UVA1 phototherapy in localized scleroderma with the cutometer and fast Fourier transform method. Dermatology. 2003;207(3):298-301.
10. Kreuter A, Hyun J, Stücker M, Sommer A, Altmeyer P, Gambichler T. A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma. J Am Acad Dermatol. 2006;54(3):440-447.
11. Tuchinda C, Kerr HA, Taylor CR, et al. UVA1 phototherapy for cutaneous diseases: an experience of 92 cases in the United States. Photodermatol Photoimmunol Photomed. 2006;22(5):247-253.
12. Kreuter A, Gambichler T, Avermaete A, et al. Low-dose ultraviolet A1 phototherapy for extragenital lichen sclerosus: results of a preliminary study. J Am Acad Dermatol. 2002;46(2):251-255.
13. Beattie PE, Dawe RS, Ferguson J, Ibbotson SH. UVA1 phototherapy for genital lichen sclerosus. Clin Exp Dermatol. 2006;31(3):343-347.
14. Ständer H, Schiller M, Schwarz T. UVA1 therapy for sclerodermic graft-versus-host disease of the skin. J Am Acad Dermatol. 2002;46(5):799-800.
15. Calzavara Pinton P, Porta F, Izzi T, et al. Prospects for ultraviolet A1 phototherapy as a treatment for chronic cutaneous graft-versus-host disease. Haematologica. 2003;88(10):1169-1175.
16. Kreuter A, Breuckmann F, Uhle A, et al. Low-dose UVA1 phototherapy in systemic sclerosis: effects on acrosclerosis. J Am Acad Dermatol. 2004;50(5): 740-747.
17. Durand F, Staumont D, Bonnevalle A, Hachulla E, Hatron PY, Thomas P. Ultraviolet A1 phototherapy for treatment of acrosclerosis in systemic sclerosis: controlled study with half-side comparison analysis. Photodermatol Photoimmunol Photomed. 2007;23(6):215-221.
18. Hatamochi A, Ono M, Arakawa M, Takeda K, Ueki H. Analysis of collagen gene expression by cultured fibroblasts in morphoea. Br J Dermatol. 1992;126(3): 216-221.
19. Wlaschek M, Heinen G, Postwig A, Schwarz A, Krieg T, Scharffetter- Kochanek K. UVA-induced autocrine stimulation of fibroblast-derived-collagenase/ MMP-1 by interrelated loops of interleukin-1 and interleukin-6. Photochem Photobiol. 1994;59(5):550-556.
20. Breuckmann F, Stuecker M, Altmeyer P, Kreuter A. Modulation of endothelial dysfunction and apoptosis: UVA1-mediated skin improvement in systemic sclerosis. Arch Dermatol Res. 2004;296(5):235-239.
21. Scharffetter K, Wlaschek M, Hogg A, et al. UVA irradiation induces collagenase in human dermal fibroblasts in vitro and in vivo. Arch Dermatol Res. 1991; 283(8):506-511.
22. Gruss C, Reed JA, Altmeyer P, Mc Nutt NS, Kerscher M. Induction of interstitial collagenase (MMP-1) by UVA-1 phototherapy in morphea fibroblasts. Lancet. 1997;350(9087):1295-1296.
23. Clements P, Lachenbruch P, Siebold J, et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol. 1995;22(7):1281-1285.
24. Kikuchi K, Sato S, Kadono T, Ihn H, Takehara K. Serum concentration of procollagen type I carboxyterminal propeptide in localized scleroderma. Arch Dermatol. 1994;130(10):1269-1272.
25. Ihn H, Sato S, Fujimoto M, Kikuchi K, Takehara K. Demonstration of interleukin 8 in serum samples of patients with localized scleroderma. Arch Dermatol. 1994; 130(10):1327-1328.
26. Hashikabe M, Ohtsuka T, Yamazaki S. Quantitative echographic analysis of photochemotherapy on systemic sclerosis skin. Arch Dermatol Res. 2005;296 (11):522-527.
27. Martini G, Murray KJ, Howell KJ, et al. Juvenile-onset localized scleroderma activity detection by infrared thermography. Rheumatology (Oxford). 2002;41 (10):1178-1182.
28. Weibel L, Howell KJ, Visentin MT, et al. Laser Doppler flowmetry for assessing localized scleroderma in children. Arthritis Rheum. 2007;56(10):3489-3495.
29. Sapadin AN, Fleischmajer R. Treatment of scleroderma. Arch Dermatol. 2002;138 (1):99-105.
30. Chung L, Lin J, Furst DE, Fiorentino D. Systemic and localized scleroderma. Clin Dermatol. 2006;24(5):374-392.
31. Kreuter A, Gambichler T, Breuckmann F, et al. Pulsed high-dose corticosteroids combined with low-dose methotrexate in severe localized scleroderma. Arch Dermatol. 2005;141(7):847-852.
32. Weibel L, Sampaio MC, Visentin MT, Howell KJ, Woo P, Harper JI. Evaluation of methotrexate and corticosteroids for the treatment of localized scleroderma (morphoea) in children. Br J Dermatol. 2006;155(5):1013-1020.
33. Dawe RS. Ultraviolet A1 phototherapy. Br J Dermatol. 2003;148(4):626-637.